Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

NCT04515238

Conditions
Chronic Lymphoid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Hamatologische/Onkologische Gemeinschaftspraxis Augsburg, Germany
  • Universitätsklinik Köln Cologne, Germany
  • Onkologische Schwerpunktpraxis Esslingen am Neckar, Germany
  • Evangelische Krankenhaus Hamm Hamm, Germany
View Trial Details
Active, Not Recruiting

Study of HMPL-760 Plus R-GemOx Versus Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

NCT06601504

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China
  • Guangxi Medical University Cancer Hospital Nanning, Guangxi, China
  • Wuhan Union Hospital of China Wuhan, Hebei, China
View all 16 locations
View Trial Details
Active, Not Recruiting

Study of 3D189 in Patients With Hematologic Malignancies

NCT05320809

Conditions
Acute Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations
  • Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital Of Nanchang University Nanchang, Jiangxi, China
  • Shengjing Hospital of China Medical Shengyang, Liaoning, China
  • Blood Disease Hospital , Chinese Academy of Medical Science Tianjing, China
View Trial Details
Active, Not Recruiting

Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT04649073

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Tokai University Hospital Isehara-shi, Japan
  • Nagoya City University Hospital Nagoya, Japan
  • National Hospital Organization Okayama Medical Center Okayama, Japan
  • Sapporo Medical University Hospital Sapporo, Japan
View Trial Details

Related conditions